These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
139 related articles for article (PubMed ID: 34680258)
1. Neuroendocrine Differentiation in Conventional Colorectal Adenocarcinomas: Incidental Finding or Prognostic Biomarker? Konukiewitz B; Kasajima A; Schmitt M; Schwamborn K; Groll T; Schicktanz F; Delbridge C; Schütze LM; Wilhelm D; Lang C; Lange S; Foersch S; Jank P; Steiger K; Werder AV; Denkert C; Weichert W; Klöppel G; Jesinghaus M Cancers (Basel); 2021 Oct; 13(20):. PubMed ID: 34680258 [TBL] [Abstract][Full Text] [Related]
2. High expression of insulinoma-associated protein 1 (INSM1) distinguishes colorectal mixed and pure neuroendocrine carcinomas from conventional adenocarcinomas with diffuse expression of synaptophysin. Litmeyer AS; Konukiewitz B; Kasajima A; Foersch S; Schicktanz F; Schmitt M; Kellers F; Grass A; Jank P; Lehman B; Gress TM; Rinke A; Bartsch DK; Denkert C; Weichert W; Klöppel G; Jesinghaus M J Pathol Clin Res; 2023 Nov; 9(6):498-509. PubMed ID: 37608427 [TBL] [Abstract][Full Text] [Related]
3. Prognostic significance of neuroendocrine components in gastric carcinomas. Park JY; Ryu MH; Park YS; Park HJ; Ryoo BY; Kim MG; Yook JH; Kim BS; Kang YK Eur J Cancer; 2014 Nov; 50(16):2802-9. PubMed ID: 25201164 [TBL] [Abstract][Full Text] [Related]
4. Microsatellite unstable gastrointestinal neuroendocrine carcinomas: a new clinicopathologic entity. Sahnane N; Furlan D; Monti M; Romualdi C; Vanoli A; Vicari E; Solcia E; Capella C; Sessa F; La Rosa S Endocr Relat Cancer; 2015 Feb; 22(1):35-45. PubMed ID: 25465415 [TBL] [Abstract][Full Text] [Related]
5. Role of Synaptophysin, Chromogranin and CD56 in adenocarcinoma and squamous cell carcinoma of the lung lacking morphological features of neuroendocrine differentiation: a retrospective large-scale study on 1170 tissue samples. Kriegsmann K; Zgorzelski C; Muley T; Christopoulos P; Thomas M; Winter H; Eichhorn M; Eichhorn F; von Winterfeld M; Herpel E; Goeppert B; Stenzinger A; Herth FJF; Warth A; Kriegsmann M BMC Cancer; 2021 May; 21(1):486. PubMed ID: 33933015 [TBL] [Abstract][Full Text] [Related]
6. Mixed adenoneuroendocrine carcinoma of the ampulla of Vater: A case report. Max N; Rothe A; Langner C Mol Clin Oncol; 2016 Jul; 5(1):95-98. PubMed ID: 27330774 [TBL] [Abstract][Full Text] [Related]
7. Gastrointestinal mixed adenoneuroendocrine carcinoma (MANEC): An immunohistochemistry study of 13 microsatellite stable cases. Gurzu S; Fetyko A; Bara T; Banias L; Butiurca VO; Bara T; Tudorache V; Jung I Pathol Res Pract; 2019 Dec; 215(12):152697. PubMed ID: 31704155 [TBL] [Abstract][Full Text] [Related]
8. Gastric mixed adenoneuroendocrine carcinoma: correlation of histologic characteristics with prognosis. Nie L; Li M; He X; Feng A; Wu H; Fan X Ann Diagn Pathol; 2016 Dec; 25():48-53. PubMed ID: 27806846 [TBL] [Abstract][Full Text] [Related]
9. Mixed Adenoneuroendocrine Carcinomas (MANECs) of the Gastrointestinal Tract: An Update. La Rosa S; Marando A; Sessa F; Capella C Cancers (Basel); 2012 Jan; 4(1):11-30. PubMed ID: 24213223 [TBL] [Abstract][Full Text] [Related]
10. Presence of RB1 or Absence of LRP1B Mutation Predicts Poor Overall Survival in Patients with Gastric Neuroendocrine Carcinoma and Mixed Adenoneuroendocrine Carcinoma. Song IH; Ahn B; Park YS; Kim DH; Hong SM Cancer Res Treat; 2024 Sep; ():. PubMed ID: 39327909 [TBL] [Abstract][Full Text] [Related]
11. Ki67 proliferative index of the neuroendocrine component drives MANEC prognosis. Milione M; Maisonneuve P; Pellegrinelli A; Grillo F; Albarello L; Spaggiari P; Vanoli A; Tagliabue G; Pisa E; Messerini L; Centonze G; Inzani F; Scarpa A; Papotti M; Volante M; Sessa F; Fazio N; Pruneri G; Rindi G; Solcia E; La Rosa S; Capella C Endocr Relat Cancer; 2018 May; 25(5):583-593. PubMed ID: 29592868 [TBL] [Abstract][Full Text] [Related]
12. Mixed adenoneuroendocrine carcinoma (MANEC) of the ampulla of Vater in a Chinese patient: A case report. Li X; Li D; Sun X; Lv G J Int Med Res; 2020 Aug; 48(8):300060520947918. PubMed ID: 32833541 [TBL] [Abstract][Full Text] [Related]
13. Characterization of genome-wide copy number aberrations in colonic mixed adenoneuroendocrine carcinoma and neuroendocrine carcinoma reveals recurrent amplification of PTGER4 and MYC genes. Sinha N; Gaston D; Manders D; Goudie M; Matsuoka M; Xie T; Huang WY Hum Pathol; 2018 Mar; 73():16-25. PubMed ID: 28899736 [TBL] [Abstract][Full Text] [Related]
14. Clinicopathologic study of mixed adenoneuroendocrine carcinomas of hepatobiliary organs. Harada K; Sato Y; Ikeda H; Maylee H; Igarashi S; Okamura A; Masuda S; Nakanuma Y Virchows Arch; 2012 Mar; 460(3):281-9. PubMed ID: 22358181 [TBL] [Abstract][Full Text] [Related]
15. Clinicopathological and Prognostic Evaluations of Mixed Adenoneuroendocrine Carcinoma of the Colon and Rectum: A Case-Matched Study. Watanabe J; Suwa Y; Ota M; Ishibe A; Masui H; Nagahori K; Tsuura Y; Endo I Dis Colon Rectum; 2016 Dec; 59(12):1160-1167. PubMed ID: 27824701 [TBL] [Abstract][Full Text] [Related]
16. The Prognostic Significance of Neuroendocrine Differentiation in Colorectal Carcinomas: Our Experience. Suresh PK; Sahu KK; Pai RR; Sridevi HB; Ballal K; Khandelia B; Minal J; Annappa R J Clin Diagn Res; 2015 Dec; 9(12):EC01-4. PubMed ID: 26816894 [TBL] [Abstract][Full Text] [Related]
17. [Gastrointestinal mixed adenoneuroendocrine carcinomas. An attempt at classification of mixed cancers]. Reu S; Neumann J; Kirchner T Pathologe; 2012 Feb; 33(1):31-8. PubMed ID: 22293787 [TBL] [Abstract][Full Text] [Related]
18. Is neuroendocrine differentiation useful to discriminate primary sinonasal intestinal-type adenocarcinomas from metastatic colorectal adenocarcinomas? Projetti F; Serrano E; Vergez S; Bissainthe AC; Delisle MB; Uro-Coste E J Clin Pathol; 2015 Jan; 68(1):79-82. PubMed ID: 25294889 [TBL] [Abstract][Full Text] [Related]
19. [Clinicopathologic characteristics of colorectal neuroendocrine tumor]. Jung SH; Kim HC; Yu CS; Chang HM; Ryu MH; Lee JL; Kim JS; Kim JC Korean J Gastroenterol; 2006 Aug; 48(2):97-103. PubMed ID: 16929153 [TBL] [Abstract][Full Text] [Related]
20. Neuroendocrine tissue-specific transcription factor, BETA2/NeuroD, in gastric carcinomas: a comparison with chromogranin A and synaptophysin expressions. Fujii A; Kamiakito T; Takayashiki N; Fujii T; Tanaka A Pathol Res Pract; 2003; 199(8):513-9. PubMed ID: 14533935 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]